The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
Intas Pharmaceuticals has appointed Girish Bhunje as Senior Vice President – API Operations
Rathi brings more than 15 years of experience in formulation research and development, with deep expertise across a wide range of dosage forms and drug delivery technologies.
Unified digital platform enables medicine price verification and grievance redressal in one place
The amendments notified under the Clinical Establishments Act, 2010 form part of this broader reform initiative aimed at creating a more responsive and facilitative regulatory ecosystem
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,
Subscribe To Our Newsletter & Stay Updated
